A unique service offering to accelerate research into cardiometabolic diseases
The ICAN IHU has structured a unique service offering in the form of scientific platforms to accelerate research into cardiometabolic diseases.
- These scientific platforms support the research mission of the IHU’s scientific and medical community .
- They are open to academic and industrial collaborations .
- Innovation is at the heart of their operation, and their complementary nature is a factor in accelerating scientific projects.
The ICAN IHU has developed exceptional operational and human resources to structure the conditions necessary for the emergence of multidisciplinary management of cardiometabolic diseases. Today, the ICAN IHU is able to offer high-level human expertise and high-performance services with strong scientific added value.
All our scientific platforms
ICAN Omics
Metabolomics and Lipidomics
ICAN BioCollection
Biological resource centre
ICAN BioCell IPS
Differentiation and genomic editing of iPS, cardiac organoids
ICAN BioCell Human Liver Biology
Human liver tissue and cell models
ICAN I/O – Data sciences
New hope in the treatment of MASH (NASH) with hepatic fibrosis
All our clinical research centres
ICAN Imaging
Cardiovascular MRI and Image Analysis (MRI, CT)
ICAN Clinical Investigation
Clinical investigation platform
